Skip to main content
. Author manuscript; available in PMC: 2022 Sep 20.
Published in final edited form as: Pediatr Res. 2019 May 13;86(2):254–260. doi: 10.1038/s41390-019-0419-3

Table 2:

Trial Demographics by Treatment Group

Demographic Placebo (N=22) 1.5 mg/kg rhCC10 (N=22) Placebo (N=21) 5 mg/kg rhCC10 (N=23)
Region – N (%)
 US
 Poland
22 (100)
N/A
22 (100)
N/A
10 (48)
11 (52)
11 (48)
12 (52)
White - N (%) 9 (41) 12 (55) 15 (71) 18 (78)
Hispanic ethnicity – N (%) 5 (23) 7 (32) 5 (24) 5 (22)
Female – N (%) 12 (55) 8 (36) 8 (38) 12 (52)
Mean gestational age at birth (SD) – weeks 26.1 (1.3) 26.5 (1.1) 27.0 (1.3) 26.6 (1.2)
Mean birth weight (SD) – grams 877.4 (170.9) 859.3 (140.9) 885.5 (173.9) 867.2 (187.2)
Median 5 minute APGAR score (IQR) 8 (7, 8) 7 (6, 8) 7 (7, 8) 7 (6, 8)

SD – Standard Deviation; IQR – Interquartile Range; N/A – not applicable